Embrella Cardiovascular (Malvern, PA) an early-stage medical device company focused on cerebral embolic protection during cardiovascular procedures, closed a $1.6M Series B bring the total financing to $6.7M. Participants include BioStarVentures, Edwards Lifesciences and MedFocus Fund.